IRMD Form 3: Director Joe E. Kiani Files Initial Statement, No Securities Owned

Rhea-AI Filing Summary

Joe E. Kiani, a director of iRadimed Corporation (IRMD), filed an initial Form 3 reporting the event dated 09/02/2025. The filing states that the reporting person does not beneficially own any securities of the issuer as of the filing. The signature on the form is dated 09/10/2025.

Positive

• None.

Negative

• Reporting person disclosed no beneficial ownership of iRadimed common stock or derivative securities as of the filing.

Insights

Corporate Governance Expert

TL;DR: Director filed an initial ownership statement and reported no holdings.

The Form 3 documents that a director-level reporting person, Joe E. Kiani, submitted an initial Section 16 filing for iRadimed Corporation and indicated zero beneficial ownership. From a governance perspective, an insider with no reported holdings reduces potential conflicts of interest disclosed via Section 16 but also means there is no insider-aligned equity stake disclosed in public filings. The filing is routine and informational; it does not itself change corporate control or financial metrics.

Securities Compliance Analyst

TL;DR: Compliance filing completed; no derivative or non-derivative positions disclosed.

The Form 3 satisfies the initial reporting obligation under Section 16 for a director by documenting the date of the triggering event and the absence of both non-derivative and derivative securities. The signature and dates are present, and there are no amendments or additional holdings reported. This is a standard disclosure with no direct market impact.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

KIANI JOE E

(Last) (First) (Middle)

C/O IRADIMED CORPORATION

12705 INGENUITY DRIVE

(Street)

ORLANDO FL 32826

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/02/2025

3. Issuer Name and Ticker or Trading Symbol
IRADIMED CORP [ IRMD ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Joe E. Kiani	09/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Joe E. Kiani report on Form 3 for IRMD?

The filing states that Joe E. Kiani, a director of iRadimed Corporation (IRMD), does not beneficially own any securities of the issuer as reported on the Form 3.

What are the key dates on the Form 3 for IRMD?

The event requiring the statement is dated 09/02/2025 and the Form 3 is signed by the reporting person on 09/10/2025.

Did the Form 3 disclose any derivative securities for IRMD?

No. The Form 3 indicates no non-derivative or derivative securities are beneficially owned by the reporting person.

Is this Form 3 an amendment or an initial filing?

This is an initial Form 3 filing (Initial Statement of Beneficial Ownership); no amendment date is provided.

Does the Form 3 indicate joint filing or multiple reporting persons?

The form indicates it was filed by one reporting person (the reporting person checkbox for one filer is checked).